At FAMA by Vitro, our commitment to continuous improvement drives us to adopt tools and models that guide us toward excellence. One of the fundamental pillars on this journey is the Excellence Model (VOPEX), a key instrument for developing our organization’s capabilities and competencies.
The Excellence Model, known as VOPEX, aims to guide our actions toward strengthening organizational capabilities and key competencies. This approach allows us to create competitive advantages and ensure the sustainability of our company. VOPEX is not just a framework, but a mindset that steers every FAMA team member toward continuous improvement and performance excellence.
What benefits does FAMA gain?
Adopting the VOPEX model has been a catalyst for creating value, not only in our operations but also through changes in our organizational behavior. Some of the benefits we have observed include:
Value creation mindset: The entire team is focused on adding value in every process and operation.
Effective communication: Collaboration and information flow between departments have been strengthened.
Effective action and execution: Agile and well-informed decision-making is promoted.
Recognition of effort: Team achievements are acknowledged, motivating constant improvement.
These elements enable us to advance towards excellence in our practices, processes, and management systems, resulting in a positive and measurable impact on our overall performance.
What are the benefits for customers?
Although the current focus of VOPEX is primarily internal, FAMA’s customers also benefit indirectly. By implementing VOPEX, we ensure constant monitoring of their products, guarantee deliveries that meet the expected quality, and react quickly to any defects or issues. Moreover, the model ensures that all our staff possess the necessary skills to perform efficient and safe operations, providing peace of mind and confidence to our customers.
Recognition of effort: The FAMA Award
On October 3rd, during the 6th edition of the Vitro Excellence Model Convention, the progress and results of the evaluations carried out at various Vitro plants were presented. We are proud to announce that FAMA received the Silver Award for having reached the level of standardization in our systems.
This achievement reflects the effort and dedication of all the leaders and operational staff who have applied the VOPEX model with determination. We deeply appreciate their commitment and challenge them to keep moving forward to meet next year’s goals, consolidating FAMA as a benchmark of excellence within Vitro.
